packageSilodosin

silodosin

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Silodosin is an alpha-blocker used to treat urinary symptoms caused by benign prostatic hyperplasia. It is an approved medicine, authorised in the European Union for prostatic hyperplasia, and is also being investigated for other uses.

Summary written by glm-5.3-flash from Wikidata Q411770 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:silodosin
ATC codes:G04CA04
DrugBank:DB06207
PubChem CID:5312125
ChEBI:135929
Wikidata:Q411770
formula:C25H32F3N3O4
molar mass:495.542 g/mol (PubChem CID 5312125)
logP:3.6 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown